124 related articles for article (PubMed ID: 17233738)
1. Essential crosstalk between myeloid and lymphoid cells for development of chronic colitis in myeloid-specific signal transducer and activator of transcription 3-deficient mice.
Reindl W; Weiss S; Lehr HA; Förster I
Immunology; 2007 Jan; 120(1):19-27. PubMed ID: 17233738
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice.
Kobayashi M; Kweon MN; Kuwata H; Schreiber RD; Kiyono H; Takeda K; Akira S
J Clin Invest; 2003 May; 111(9):1297-308. PubMed ID: 12727921
[TBL] [Abstract][Full Text] [Related]
3. Lymphotoxin-beta receptor activation on macrophages ameliorates acute DSS-induced intestinal inflammation in a TRIM30α-dependent manner.
Wimmer N; Huber B; Wege AK; Barabas N; Röhrl J; Pfeffer K; Hehlgans T
Mol Immunol; 2012 Jun; 51(2):128-35. PubMed ID: 22437076
[TBL] [Abstract][Full Text] [Related]
4. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.
Sakata A; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Toda A; Eyanagi R; Soeda S
Immunology; 2007 Sep; 122(1):54-64. PubMed ID: 17451462
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
Iwata-Kajihara T; Sumimoto H; Kawamura N; Ueda R; Takahashi T; Mizuguchi H; Miyagishi M; Takeda K; Kawakami Y
J Immunol; 2011 Jul; 187(1):27-36. PubMed ID: 21632716
[TBL] [Abstract][Full Text] [Related]
6. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis.
Ostanin DV; Furr KL; Pavlick KP; Gray L; Kevil CG; Shukla D; D'Souza D; Hoffman JM; Grisham MB
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1706-14. PubMed ID: 17332469
[TBL] [Abstract][Full Text] [Related]
7. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
[TBL] [Abstract][Full Text] [Related]
8. Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice.
Willson TA; Jurickova I; Collins M; Denson LA
Inflamm Bowel Dis; 2013 Mar; 19(3):512-25. PubMed ID: 23429443
[TBL] [Abstract][Full Text] [Related]
9. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic STAT3 protects mice against caerulein-induced pancreatitis via PAP1 induction.
Shigekawa M; Hikita H; Kodama T; Shimizu S; Li W; Uemura A; Miyagi T; Hosui A; Kanto T; Hiramatsu N; Tatsumi T; Takeda K; Akira S; Takehara T
Am J Pathol; 2012 Dec; 181(6):2105-13. PubMed ID: 23064197
[TBL] [Abstract][Full Text] [Related]
11. Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells.
Däbritz J; Judd LM; Chalinor HV; Menheniott TR; Giraud AS
Sci Rep; 2016 Feb; 6():20584. PubMed ID: 26848037
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.
Jauch D; Martin M; Schiechl G; Kesselring R; Schlitt HJ; Geissler EK; Fichtner-Feigl S
Gut; 2011 Dec; 60(12):1678-86. PubMed ID: 21948944
[TBL] [Abstract][Full Text] [Related]
13. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
Matsumoto S; Hara T; Mitsuyama K; Yamamoto M; Tsuruta O; Sata M; Scheller J; Rose-John S; Kado S; Takada T
J Immunol; 2010 Feb; 184(3):1543-51. PubMed ID: 20042582
[TBL] [Abstract][Full Text] [Related]
14. IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.
Tomita T; Kanai T; Totsuka T; Nemoto Y; Okamoto R; Tsuchiya K; Sakamoto N; Ohteki T; Hibi T; Watanabe M
Eur J Immunol; 2009 Oct; 39(10):2737-47. PubMed ID: 19637223
[TBL] [Abstract][Full Text] [Related]
15. The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis.
Sheng YH; Lourie R; Lindén SK; Jeffery PL; Roche D; Tran TV; Png CW; Waterhouse N; Sutton P; Florin TH; McGuckin MA
Gut; 2011 Dec; 60(12):1661-70. PubMed ID: 21636645
[TBL] [Abstract][Full Text] [Related]
16. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
Carl VS; Gautam JK; Comeau LD; Smith MF
J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
[TBL] [Abstract][Full Text] [Related]
17. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.
Sawa S; Kamimura D; Jin GH; Morikawa H; Kamon H; Nishihara M; Ishihara K; Murakami M; Hirano T
J Exp Med; 2006 Jun; 203(6):1459-70. PubMed ID: 16717113
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.
Fukata M; Michelsen KS; Eri R; Thomas LS; Hu B; Lukasek K; Nast CC; Lechago J; Xu R; Naiki Y; Soliman A; Arditi M; Abreu MT
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1055-65. PubMed ID: 15826931
[TBL] [Abstract][Full Text] [Related]
20. The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.
Spalinger MR; Sayoc-Becerra A; Ordookhanian C; Canale V; Santos AN; King SJ; Krishnan M; Nair MG; Scharl M; McCole DF
J Crohns Colitis; 2021 Mar; 15(3):471-484. PubMed ID: 32909045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
